Trillium Asset Management LLC lifted its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 1.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 92,950 shares of the medical research company’s stock after purchasing an additional 1,135 shares during […]